Clinical trial
A Trial of Chemo & Radiation Therapy for Pancreatic Cancer
NCT00424827 · University of Massachusetts, Worcester, Other · Completed
Key facts
| NCT number | NCT00424827 |
|---|---|
| Title | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer |
| Official title | A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil and Radiation Therapy in Locally Advanced Non-metastatic Pancreatic Adenocarcinoma |
| Lead sponsor | University of Massachusetts, Worcester, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine/Fluorouracil with External Beam Radiation |
| Enrollment | 11 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Jan 22, 2007 |
| Last update posted | Jun 1, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: